Fernando Avila
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fernando Avila has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
C. Bermudez
3 shared publicationsY. Toyoda
3 shared publications- Daniel S. Elson
Imperial College London
2 shared publications R. Kormos
2 shared publicationsS. Mulukutla
2 shared publicationsA. Girnita
1 shared publication
Latest Publications
- 1 January 2020
- Published by Optica Publishing Group
- p. TW2B.3
Snapshot Hyperspectral System for Breast Conserving Surgery Guidance
There is an unmet need for accurate tumour localization in vivo during breast conserving surgery. Herein a novel snapshot hyperspectral system is presented for accurately detecting the intrinsic fluorescence signal in real-time fluorescence guided surgery.
- 1 January 2020
- Published by Optica Publishing Group
- p. TW2B.3
Snapshot Hyperspectral System for Breast Conserving Surgery Guidance
There is an unmet need for accurate tumour localization in vivo during breast conserving surgery. Herein a novel snapshot hyperspectral system is presented for accurately detecting the intrinsic fluorescence signal in real-time fluorescence guided surgery.
- Open Access
- 1 January 2018
- Published by Optica Publishing Group
- p. CF1B.5
Robotic Wide-Field Optical Biopsy Endoscopy
This paper describes a novel robotic framework for wide-field optical biopsy endoscopy, characterizes in vitro its spatial and spectral resolution, real time hyperspectral tissue classification, and demonstrates its feasibility on fresh porcine cadaveric colon.
- 1 January 2018
- Published by Optica Publishing Group
- p. CF1B.5
Open AccessRobotic Wide-Field Optical Biopsy Endoscopy
This paper describes a novel robotic framework for wide-field optical biopsy endoscopy, characterizes in vitro its spatial and spectral resolution, real time hyperspectral tissue classification, and demonstrates its feasibility on fresh porcine cadaveric colon.
- 1 May 2015
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1757-1763
Towards a robotic-assisted cartography of the colon: A proof of concept
Colonoscopy is the gold standard screening test for colorectal cancer. However, it can miss up to 22% of lesions. One way to reduce this misrate is by guiding the endoscopist's attention towards suspicious areas (red-flagging). In this paper, we present the proof-of-concept of a novel endoscopic imaging device for the scanning of tubular organs such as the colon and the esophagus. The envisaged concept works as an accessory for any conventional flexible endoscope using it as a rail. It can generate a red-flagged map of the whole organ by orbiting and sliding a radial array of optical sensors around and along the endoscope. This concept paves the way for a semi-automated concurrent red-flagging technique for colonoscopy that enhances the endoscopist's situational awareness and reduces misrate.
- 1 May 2015
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1757-1763
Towards a robotic-assisted cartography of the colon: A proof of concept
Colonoscopy is the gold standard screening test for colorectal cancer. However, it can miss up to 22% of lesions. One way to reduce this misrate is by guiding the endoscopist's attention towards suspicious areas (red-flagging). In this paper, we present the proof-of-concept of a novel endoscopic imaging device for the scanning of tubular organs such as the colon and the esophagus. The envisaged concept works as an accessory for any conventional flexible endoscope using it as a rail. It can generate a red-flagged map of the whole organ by orbiting and sliding a radial array of optical sensors around and along the endoscope. This concept paves the way for a semi-automated concurrent red-flagging technique for colonoscopy that enhances the endoscopist's situational awareness and reduces misrate.
- 1 February 2010
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 29 (2) , S179-S180
552: Use of Extracorporeal Membrane Oxygenation (ECMO) in Patients with Chronic Cardiomyopathy: A Word of Caution
- 1 February 2010
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 29 (2) , S179-S180
552: Use of Extracorporeal Membrane Oxygenation (ECMO) in Patients with Chronic Cardiomyopathy: A Word of Caution
- 28 February 2009
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 28 (2) , S273
597: Use of Extracorporeal Membrane Oxygenation in Advanced Cardiogenic Shock Complicating an Acute Myocardial Infarction
- 28 February 2009
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 28 (2) , S273
597: Use of Extracorporeal Membrane Oxygenation in Advanced Cardiogenic Shock Complicating an Acute Myocardial Infarction
- 1 February 2009
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 28 (2) , S136
200: Clinical Experience with the Use of Virtual Crossmatch in Adult Lung Transplantation
- 1 February 2009
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 28 (2) , S136
200: Clinical Experience with the Use of Virtual Crossmatch in Adult Lung Transplantation
- Top Cited Papers
- 1 August 2003
- Published by Wolters Kluwer Health in Hypertension
- Vol. 42 (2) , 161-165
Primary Aldosteronism and Hypertensive Disease
Recent studies in hypertensive populations that have used the serum aldosterone (SA) to plasma renin activity (PRA) ratio as a screening test have demonstrated a high prevalence of primary aldosteronism (PA). This frequency is higher than that previously described when hypokalemia was used as a screening tool. However, other factors, such as the characteristics of hypertensive disease, could also influence the prevalence of PA. We studied 609 essential hypertensive patients, classified according to the Joint National Committee VI (JNC VI), in 3 different stages depending on the severity of their hypertensive disease. We measured SA and PRA and calculated the SA-PRA ratio for all patients. An SA-PRA ratio >25 was detected in 63 of 609 patients, and the fludrocortisone test confirmed the PA diagnoses in 37 of 609 (6.1%) cases. PA prevalence according to hypertension stage was as follows: stage 1, 6 of 301 cases (1.99%); stage 2, 15 of 187 cases (8.02%); and stage 3, 16 of 121 cases (13.2%). PA patients were slightly younger than the other hypertensive patients (48.4±10.5 vs 53.6±10.2 years; P <0.05). Serum potassium levels were normal in 36 of 37 PA patients; only 1 patient had minor hypokalemia. Computed tomography scans showed bilateral adrenal enlargement in 7 and an adrenal nodule in 2 cases. In summary, we found a high frequency of PA in essential hypertensives classified in stages 2 and 3 according to the JNC VI. The low frequency of computed tomography scan abnormalities and hypokalemia suggests that the diagnosis for most PA patients corresponds to attenuated forms of the disease.
- 1 August 2003
- Published by Wolters Kluwer Health in Hypertension
- Vol. 42 (2) , 161-165
Top Cited PapersPrimary Aldosteronism and Hypertensive Disease
Recent studies in hypertensive populations that have used the serum aldosterone (SA) to plasma renin activity (PRA) ratio as a screening test have demonstrated a high prevalence of primary aldosteronism (PA). This frequency is higher than that previously described when hypokalemia was used as a screening tool. However, other factors, such as the characteristics of hypertensive disease, could also influence the prevalence of PA. We studied 609 essential hypertensive patients, classified according to the Joint National Committee VI (JNC VI), in 3 different stages depending on the severity of their hypertensive disease. We measured SA and PRA and calculated the SA-PRA ratio for all patients. An SA-PRA ratio >25 was detected in 63 of 609 patients, and the fludrocortisone test confirmed the PA diagnoses in 37 of 609 (6.1%) cases. PA prevalence according to hypertension stage was as follows: stage 1, 6 of 301 cases (1.99%); stage 2, 15 of 187 cases (8.02%); and stage 3, 16 of 121 cases (13.2%). PA patients were slightly younger than the other hypertensive patients (48.4±10.5 vs 53.6±10.2 years; P <0.05). Serum potassium levels were normal in 36 of 37 PA patients; only 1 patient had minor hypokalemia. Computed tomography scans showed bilateral adrenal enlargement in 7 and an adrenal nodule in 2 cases. In summary, we found a high frequency of PA in essential hypertensives classified in stages 2 and 3 according to the JNC VI. The low frequency of computed tomography scan abnormalities and hypokalemia suggests that the diagnosis for most PA patients corresponds to attenuated forms of the disease.
- 1 December 2000
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Boletín de la Sociedad Chilena de Química
- Vol. 45 (4) , 577-581
BIOLOGICALLY ACTIVE COMPOUNDS FROM CHILEAN PROPOLIS
- 1 December 2000
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Boletín de la Sociedad Chilena de Química
- Vol. 45 (4) , 577-581
BIOLOGICALLY ACTIVE COMPOUNDS FROM CHILEAN PROPOLIS